While still in his early twenties, painting houses in Dublin to support himself, he turned a college thesis into a successful enterprise. Carefully building up his business, he brought it to the US, braving hard knocks along the way and navigating the shark-fest of public trading. In 2021, with the help of some great partners, his company was listed on the NASDAQ.
One Nutriband product, AVERSA, has been developed as a non-abusable alternative to opiate pain medicines, providing pain management solutions for chronic pain sufferers the world over, without the risk of addiction. The company is aiming to become a billion-dollar concern, with breakthrough products in development, and trading established in 45 countries. Recently, Gareth was shortlisted for the EY Entrepreneur of the Year 2025 award.
In this book, Gareth reveals some strategic advice to other business dreamers. It is a story of strength, resilience and vision, and what can happen when you refuse to accept the word "no".
